Los Angeles Capital Management
MANE

Los Angeles Capital Management’s Veradermics Inc MANE Stock Holding History

Los Angeles Capital Management’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Buy
+252
New +$23.6K ﹤0.01% 1648

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Los Angeles Capital Management's MANE Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Veradermics Inc (MANE) in Q2 2026: 252 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #1648 among its holdings.

83 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Los Angeles Capital Management held 252 shares of Veradermics Inc worth $31K as of Q2 2026.
  • Veradermics Inc was a new Los Angeles Capital Management position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1648 holding.
  • 83 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.